FLUCICLOVINE F-18

FLUCICLOVINE F-18 was reported 102 times

FLUCICLOVINE F-18 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSITRON EMISSION TOMOGRAM ABNORMAL 22 0.0315
1 SCAN ABNORMAL 11 0.0298
2 FALSE NEGATIVE INVESTIGATION RESULT 7 0.0100
3 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
4 MANUFACTURING PRODUCT SHIPPING ISSUE 2 0.0037
5 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
6 CLAUSTROPHOBIA 1 0.0009
7 GLIOBLASTOMA 1 0.0006
8 EXTRAVASATION 2 0.0005
9 BACTERIAL TEST POSITIVE 1 0.0004
10 INJECTION SITE EXTRAVASATION 5 0.0004
11 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
12 PROSTATE CANCER METASTATIC 1 0.0003
13 WRONG PRODUCT ADMINISTERED 2 0.0003
14 BONE LESION 1 0.0003
15 INFUSION SITE EXTRAVASATION 1 0.0002
16 INTENTIONAL UNDERDOSE 1 0.0001
17 NO ADVERSE EVENT 18 0.0001
18 EYE DISCHARGE 1 0.0001
19 DECREASED ACTIVITY 1 0.0001
20 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
21 CONJUNCTIVITIS 1 0.0001
22 DYSSTASIA 1 0.0000
23 EPILEPSY 1 0.0000
24 PRODUCT DOSE OMISSION 2 0.0000
25 UNDERDOSE 2 0.0000
26 EYE SWELLING 1 0.0000
27 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
28 OCULAR HYPERAEMIA 1 0.0000
29 HYPONATRAEMIA 1 0.0000
30 EYE IRRITATION 1 0.0000
31 VERTIGO 1 0.0000
32 BLOOD CREATININE INCREASED 1 0.0000
33 INJECTION SITE PRURITUS 1 0.0000
34 AGITATION 1 0.0000
35 DYSGEUSIA 1 0.0000
36 TACHYCARDIA 1 0.0000
37 OFF LABEL USE 8 0.0000
38 DEHYDRATION 1 0.0000
39 CONFUSIONAL STATE 1 0.0000
40 ABDOMINAL DISCOMFORT 1 0.0000
41 URINARY TRACT INFECTION 1 0.0000
42 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
43 MUSCLE SPASMS 1 0.0000
44 GAIT DISTURBANCE 1 0.0000
45 DIARRHOEA 3 0.0000
46 OVERDOSE 1 0.0000
47 MALAISE 2 0.0000
48 DRUG INEFFECTIVE 6 0.0000
49 VOMITING 2 0.0000
50 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
51 ANXIETY 1 0.0000
52 PAIN IN EXTREMITY 1 0.0000
53 CONDITION AGGRAVATED 1 0.0000
54 INJECTION SITE PAIN 1 0.0000
55 RASH 1 0.0000
56 DIZZINESS 1 0.0000
57 FATIGUE 1 0.0000
58 NAUSEA 1 0.0000